Diagnosis of Barrett's esophagus and esophageal neoplasia: East meets West

Digestive Endoscopy

Volumn 18, Issue SUPPL. 1, 2006, Pages

  Canto, Marcia Irene ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Barrett's esophagus; Chromoendoscopy; Endoscopic mucosal ablation; Endoscopic mucosal resection; Novel imaging

Indexed keywords

ARGON PLASMA COAGULATION; ASIA; AUTOFLUORESCENCE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SCREENING; CHROMOENDOSCOPY; CONFERENCE PAPER; CRYOTHERAPY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER; METAPLASIA; NARROW BAND IMAGING; PHOTODYNAMIC THERAPY; SAFETY; VIDEORECORDING;

EID: 33845537571     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/j.1443-1661.2006.00640.x     Document Type: Conference Paper

References (51)

1. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J. Gastroenterol. 2003; 38 (Suppl. 15): 25-30.
2. Nakamura M, Kawano T, Endo M, Iwai T. Intestinal metaplasia at the esophagogastric junction in Japanese patients without clinical Barrett's esophagus. Am. J. Gastroenterol. 1999; 94: 3145-9.
3. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344: 1533-6.
4. Clark GW, Smyrk TC, Burdiles P et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch. Surg. 1994; 129: 609-14.
5. Kim SL, Waring JP, Spechler SJ et al. Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group. Gastroenterology 1994; 107: 945-9.
6. Rex DK, Cummings OW, Shaw M et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003; 125: 1670-7.
7. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7.
8. Connor MJ, Weston AP, Mayo MS, Sharma P. The prevalence of Barrett's esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population. Dig. Dis. Sci. 2004; 49: 920-4.
9. Woolf GM, Riddell RH, Irvine EJ, Hunt RH. A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus. Gastrointest. Endosc. 1989; 35: 541-4.
10. Takubo K, Vieth M, Aryal G et al. Islands of squamous epithelium and their surrounding mucosa in columnar-lined esophagus: a pathognomonic feature of Barrett's esophagus? Hum. Pathol. 2005; 36: 269-74.
11. Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV Jr. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest. Endosc. 1996; 44: 1-7.
12. Canto MI, Setrakian S, Willis J et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest. Endosc. 2000; 51: 560-8.
13. Sharma P, Topalovski M, Mayo MS, Weston AP. Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus. Gastrointest. Endosc. 2001; 54: 289-93.
14. Sharma P, Weston AP, Topalovski M, Cherian R, Bhattacharyya A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut 2003; 52: 24-7.
15. Guelrud M, Herrera I, Essenfeld H, Castro J. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest. Endosc. 2001; 53: 559-65. Abstract.
16. Catanzaro A, Faulx A, Isenberg GA et al. Prospective evaluation of 4-mm diameter endoscopes for esophagoscopy in sedated and unsedated patients. Gastrointest. Endosc. 2003; 57: 300-4.
17. Fennerty MB, DiTomasso J, Morales TG et al. Screening for Barrett's esophagus by balloon cytology. Am. J. Gastroenterol. 1995; 90: 1230-2.
18. Falk GW, Chittajallu R, Goldblum JR et al. Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology [see comments]. Gastroenterology 1997; 112: 1787-97.
19. Shen O, Liu SF, Dawsey SM et al. Cytologic screening for esophageal cancer: results from 12 877 subjects from a high-risk population in China. Int. J. Cancer 1993; 54: 185-8.
20. Eliakim R, Yassin K, Shlomi I, Suissa A, Eisen GM. A novel diagnostic tool for detecting oesophageal pathology: the Pill-Cam oesophageal video capsule. Aliment. Pharmacol. Ther. 2004; 20: 1083-9.
21. Ramirez FC, Shaukat MS, Young MA, Johnson DA, Akins R. Feasibility and safety of string, wireless capsule endoscopy in the diagnosis of Barrett's esophagus. Gastrointest. Endosc. 2005; 61: 741-6.
22. Shaheen N, Ransohoff DF. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA 2002; 287: 1972-81.
23. Soni A, Sampliner RE, Sonnenberg A. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am. J. Gastroenterol. 2000; 95: 2086-93.
24. Gerson LB, Groeneveld PW, Triadafilopoulos G. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Clin. Gastroenterol. Hepatol. 2004; 2: 868-79.
25. Incarbone R, Bonavina L, Saino G, Bona D, Peracchia A. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg. Endosc. 2002; 16: 263-6.
26. Amano Y, Kushiyama Y, Ishihara S et al. Crystal violet chromoendoscopy with mucosal pit pattern diagnosis is useful for surveillance of short-segment Barrett's esophagus. Am. J. Gastroenterol. 2005; 100: 21-6.
27. Kara MA, Peters FP, Rosmolen WD et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. Endoscopy 2005; 37: 929-36.
28. Georgakoudi I, Jacobson BC, Van Dam J et al. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology 2001; 120: 1620-9.
29. Kara MA, Peters FP, Ten Kate FJ, Van Deventer SJ, Fockens P, Bergman JJ. Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus. Gastrointest. Endosc. 2005; 61: 679-85.
30. Poneros JM, Brand S, Bouma BE, Tearney GJ, Compton CC, Nishioka NS. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology 2001; 120: 7-12.
31. Li XD, Boppart SA, Van Dam J et al. Optical coherence tomography: advanced technology for the endoscopic imaging of Barrett's esophagus. Endoscopy 2000; 32: 921-30.
32. Kiesslich R, Neurath MF. Endoscopic confocal imaging. Clin. Gastroenterol. Hepatol. 2005; 3: S58-60.
33. Overholt BF, Panjehpour M. Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer [see comments]. Gastrointest. Endosc. 1995; 42: 64-70.
34. Overholt BF, Lightdale CJ, Wang KK et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest. Endosc. 2005; 62: 488-98.
35. Shaheen NJ, Inadomi JM, Overholt BF, Sharma P. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut 2004; 53: 1736-44.
36. Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig. Dis. Sci. 2003; 48: 1273-83.
37. Peters F, Kara M, Rosmolen W et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. Endoscopy 2005; 37: 418-24.
38. Ragunath K, Krasner N, Raman VS, Haqqani MT, Phillips CJ, Cheung I. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand. J. Gastroenterol. 2005; 40: 750-8.
39. Pasricha PJ, Hill S, Wadwa KS et al. Endoscopic cryotherapy: experimental results and first clinical use. Gastrointest. Endosc. 1999; 49: 627-31.
40. Johnston CM, Schoenfeld LP, Mysore JV, Dubois A. Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus. Gastrointest. Endosc. 1999; 50: 86-92.
41. Canto M, Kantsevoy S, Wu T, Montgomery E, Kalloo A. MB predicts dysplasia in Barrett's esophagus. Gastrointest. Endosc. 1999; 49 (4 Pt 2): AB50.
42. Dunkin BJ, Martinez J, Bejarano PA et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg. Endosc. 2006; 20: 125-30.
43. Giovannini M, Bernardini D, Moutardier V et al. Endoscopic mucosal resection (EMR): results and prognostic factors in 21 patients. Endoscopy 1999; 31: 698-701.
44. Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions [see comments]. Gastrointest. Endosc. 1993; 39: 58-62.
45. Mino-Kenudson M, Brugge WR, Puricelli WP et al. Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am. J. Surg. Pathol. 2005; 29: 680-6.
46. Wolfsen HC, Hemminger LL, Raimondo M, Woodward TA. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma. South Med. J. 2004; 97: 827-30.
47. Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000; 118: 670-7.
48. Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest. Endosc. 2001; 54: 682-8.
49. Pacifico RJ, Wang KK, Wongkeesong LM, Buttar NS, Lutzke LS. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin. Gastroenterol. Hepatol. 2003; 1: 252-7.
50. Giovannini M, Bories E, Pesenti C et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 2004; 36: 782-7.
51. Pilloud R, Jaquet Y, Monnier P. Extensive circumferential endoscopic mucosal resection with a new rigid esophagoscope: an animal study. J. Thorac. Cardiovasc. Surg. 2005; 130: 1399.